Results 37,701-37,720 of 46,260 for speaker:Simon Harris

Written Answers — Department of Health: Vaccination Programme (1 Dec 2016)

Simon Harris: Each year in Ireland around 300 women are diagnosed with cervical cancer. The HPV vaccine protects against two high risk types of HPV (16 & 18) that cause 73% of all cervical cancers. Vaccinated women and girls will still be at risk from other high risk types of HPV that can cause cervical cancer and will therefore need to continue to have regular cervical smear tests. NIAC...

Written Answers — Department of Health: Rare Diseases Strategy (1 Dec 2016)

Simon Harris: The National Rare Disease Plan for Ireland (2014 - 2018) recommended that an Oversight Implementation Group of relevant stakeholders, including patients' groups, be established to oversee and monitor implementation of the plan's recommendations. This group was established by the Department of Health in 2015 and it has met on a number of occasions. One of the principal recommendations in...

Written Answers — Department of Health: Accident and Emergency Departments (1 Dec 2016)

Simon Harris: Trolley numbers nationally have been high in November due to increased ED attendances, greater incidence of infection in several hospitals and a high rate of elective activity in hospitals to address waiting lists. The HSE has advised that there has been a 1.6% increase in attendances at the ED in St Vincent's since 2015 and a 5.3% increase in emergency discharges. Infection control issues...

Written Answers — Department of Health: Hospital Waiting Lists (1 Dec 2016)

Simon Harris: This Government is committed to improving waiting times for patients. While recognising that demand for hospital inpatient and day case activity nationally has increased by 4% year on year to end October, the important issue for patients is how long they wait. Under the HSE Service Plan 2016 targets, 95% of people should be waiting less than 15 months for their inpatient or day-case...

Written Answers — Department of Health: Hospital Services (1 Dec 2016)

Simon Harris: As this is a service matter it has been referred to the HSE for reply to you.

Written Answers — Department of Health: Medicinal Products Reimbursement (1 Dec 2016)

Simon Harris: The HSE has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.

Written Answers — Department of Health: Occupational Therapy (1 Dec 2016)

Simon Harris: As this question relates to service matters, I have arranged for the question to be referred to the Health Service Executive (HSE) for direct reply to you.

Written Answers — Department of Health: Occupational Therapy (1 Dec 2016)

Simon Harris: As this question relates to service matters, I have arranged for the question to be referred to the Health Service Executive (HSE) for direct reply to you.

Written Answers — Department of Health: Hospital Waiting Lists (1 Dec 2016)

Simon Harris: This Government is committed to improving waiting times for patients. While recognising that demand for acute hospital services has increased, the important issue for patients is how long they wait. Under the HSE Service Plan 2016 targets, 85% of people should wait less than 52 weeks for their first outpatient appointment. The latest NTPF Outpatient Waiting List figures indicate that...

Written Answers — Department of Health: Abortion Legislation (1 Dec 2016)

Simon Harris: The case to which the Deputy refers is still sub judice. Therefore, it would not be in order to comment on it.

Written Answers — Department of Health: Health Insurance Prices (1 Dec 2016)

Simon Harris: My Department has not undertaken a review into the cost of health insurance, as the main contributors to costs in the market are well established. The cost of private health insurance is influenced by a number of factors such as the number of persons in the market, the age profile of those holding private health insurance and ongoing medical innovations. Each of these are contributors to the...

Written Answers — Department of Health: Health Services Provision (1 Dec 2016)

Simon Harris: As this is a service matter it has been referred to the HSE for reply.

Written Answers — Department of Health: Medicinal Products Prices (1 Dec 2016)

Simon Harris: As outlined in previous reply, the HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. In line with the 2013 Act, if a Company would like a medicine to be reimbursed by the HSE pursuant to the Community Drug Schemes or as a hospital medicine,...

Written Answers — Department of Health: Occupational Therapy (1 Dec 2016)

Simon Harris: As this question relates to service matters, I have arranged for the question to be referred to the Health Service Executive (HSE) for direct reply to the Deputy.

Written Answers — Department of Health: Audiology Services Provision (1 Dec 2016)

Simon Harris: As this is a service matter it has been referred to the HSE for reply to the Deputy.

Written Answers — Department of Health: Medicinal Products Supply (1 Dec 2016)

Simon Harris: Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the primary care schemes; therefore, the matter has been referred to the HSE for attention and direct reply.

Written Answers — Department of Health: Medicinal Products Availability (1 Dec 2016)

Simon Harris: The manufacturer submitted an application to the HSE to have Ivacaftor, brand name Kalydeco, reimbursed for the treatment of cystic fibrosis patients aged 2 years and older weighing less than 25kg. In March of this year the HSE requested that the NCPE carry out a health technology assessment of the applicant’s economic dossier on the cost effectiveness of this treatment. In the...

Written Answers — Department of Health: Medicinal Products Data (1 Dec 2016)

Simon Harris: I propose to take Questions Nos. 215 to 218, inclusive, and 220 together. Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply.

Written Answers — Department of Health: Medicinal Products Supply (1 Dec 2016)

Simon Harris: As this is a service matter, it has been referred to the HSE for reply.

Written Answers — Department of Health: Long-Term Illness Scheme (1 Dec 2016)

Simon Harris: Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply.